Sinil Pharmaceutical Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Sinil Pharmaceutical.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi	38.2%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Little Excitement Around Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Earnings

Aug 12

Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials Driving The Negative Sentiment?

Mar 11

Is Sinil Pharmaceutical's (KOSDAQ:012790) 122% Share Price Increase Well Justified?

Feb 13

Could The Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790) Ownership Structure Tell Us Something Useful?

Jan 17

Sinil Pharmaceutical's (KOSDAQ:012790) Earnings Are Growing But Is There More To The Story?

Dec 22

Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

Nov 26

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Sinil Pharmaceutical yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

KOSDAQ:A012790 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (KRW Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2024	96,516	15,763	16,003	25,797	N/A
3/31/2024	90,064	13,505	7,818	20,267	N/A
12/31/2023	89,135	13,641	1,494	15,154	N/A
9/30/2023	86,210	12,624	-10,007	11,359	N/A
6/30/2023	81,163	11,613	-5,583	10,633	N/A
3/31/2023	83,914	13,444	-2,343	11,173	N/A
12/31/2022	80,007	12,157	3,309	13,688	N/A
9/30/2022	75,971	11,067	5,766	13,015	N/A
6/30/2022	72,082	10,343	8,690	14,181	N/A
3/31/2022	66,435	8,229	9,447	12,494	N/A
12/31/2021	61,754	6,679	7,534	11,163	N/A
9/30/2021	60,177	5,201	6,733	11,856	N/A
6/30/2021	59,435	5,407	0	7,464	N/A
3/31/2021	59,323	6,494	1,404	10,884	N/A
12/31/2020	61,438	7,544	2,159	11,062	N/A
9/30/2020	63,736	8,359	1,752	11,289	N/A
6/30/2020	63,613	8,072	6,883	14,826	N/A
3/31/2020	63,547	8,017	6,103	14,604	N/A
12/31/2019	60,648	7,257	2,569	12,306	N/A
9/30/2019	57,397	7,115	-2,083	11,872	N/A
6/30/2019	54,252	5,497	-2,083	10,138	N/A
3/31/2019	53,241	4,767	-3,112	6,987	N/A
12/31/2018	53,277	5,714	936	9,194	N/A
9/30/2018	52,442	6,385	7,016	2,244	N/A
6/30/2018	52,867	7,888	6,530	5,287	N/A
3/31/2018	51,369	8,293	N/A	10,089	N/A
12/31/2017	50,942	8,198	N/A	8,674	N/A
9/30/2017	50,545	7,731	N/A	20,427	N/A
6/30/2017	49,387	8,376	N/A	15,158	N/A
3/31/2017	49,158	8,840	N/A	10,757	N/A
12/31/2016	50,212	9,360	N/A	12,094	N/A
9/30/2016	49,134	9,432	N/A	5,350	N/A
6/30/2016	48,151	9,352	N/A	8,080	N/A
3/31/2016	46,964	9,117	N/A	7,855	N/A
12/31/2015	44,703	8,764	N/A	9,564	N/A
9/30/2015	45,240	9,405	N/A	12,112	N/A
6/30/2015	46,805	9,905	N/A	11,273	N/A
3/31/2015	47,662	10,247	N/A	10,828	N/A
12/31/2014	48,160	10,179	N/A	9,329	N/A
9/30/2014	46,421	8,927	N/A	9,139	N/A
6/30/2014	45,514	8,740	N/A	14,186	N/A
3/31/2014	44,448	7,977	N/A	10,773	N/A
12/31/2013	44,311	7,324	N/A	12,259	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if A012790's forecast earnings growth is above the savings rate (2.6%).

Kazançlar ve Piyasa: Insufficient data to determine if A012790's earnings are forecast to grow faster than the KR market

Yüksek Büyüme Kazançları: Insufficient data to determine if A012790's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if A012790's revenue is forecast to grow faster than the KR market.

Yüksek Büyüme Geliri: Insufficient data to determine if A012790's revenue is forecast to grow faster than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if A012790's Return on Equity is forecast to be high in 3 years time

Sinil Pharmaceutical Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

Little Excitement Around Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Earnings

Upcoming dividend of ₩96.15 per share at 1.3% yield

New major risk - Earnings quality

Third quarter 2023 earnings released: EPS: ₩300 (vs ₩213 in 3Q 2022)

First quarter 2023 earnings released: EPS: ₩329 (vs ₩217 in 1Q 2022)

Upcoming dividend of ₩97.09 per share

Less than half of directors are independent

Now 22% undervalued after recent price drop

Now 20% undervalued

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Inaugural dividend of ₩97.09 per share

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials Driving The Negative Sentiment?

Is Sinil Pharmaceutical's (KOSDAQ:012790) 122% Share Price Increase Well Justified?

Could The Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790) Ownership Structure Tell Us Something Useful?

New 90-day low: ₩19,000

Investor sentiment deteriorated over the past week

Sinil Pharmaceutical's (KOSDAQ:012790) Earnings Are Growing But Is There More To The Story?

Market bids up stock over the past week

Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

New 90-day low: ₩20,300

New 90-day low: ₩24,300

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin